Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma
一项多中心随机对照试验,比较新辅助放化疗单独使用或联合帕博利珠单抗治疗可切除或临界可切除胰腺腺癌患者的疗效
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-007586
Katz, Matthew H G; Petroni, Gina R; Bauer, Todd; Reilley, Matthew J; Wolpin, Brian M; Stucky, Chee-Chee; Bekaii-Saab, Tanios S; Elias, Rawad; Merchant, Nipun; Dias Costa, Andressa; Lenehan, Patrick; Cardot-Ruffino, Victoire; Rodig, Scott; Pfaff, Kathleen; Dougan, Stephanie K; Nowak, Jonathan Andrew; Varadhachary, Gauri R; Slingluff, Craig L; Rahma, Osama